These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 10902236

  • 1. Treatment strategies for hepatitis C: making the best of limited options.
    McHutchison JG, Younossi Z.
    Cleve Clin J Med; 2000 Jul; 67(7):476-80. PubMed ID: 10902236
    [Abstract] [Full Text] [Related]

  • 2. [Combination therapy of interferon plus ribavirin for chronic hepatitis C].
    Asahina Y, Izumi N.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].
    Fukuda A.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):493-6. PubMed ID: 15359848
    [No Abstract] [Full Text] [Related]

  • 4. Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
    de Lédinghen V, Trimoulet P, Winnock M, Foucher J, Bourlière M, Desmorat H, Canva V, Capron D, Lévy S, Mion F, Mannant PR, Chêne G, Fleury H, Couzigou P, Bernard PH, French Multicenter Study Group.
    J Hepatol; 2002 May; 36(5):672-80. PubMed ID: 11983451
    [Abstract] [Full Text] [Related]

  • 5. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF, Fuentes AP, Olivera-Martinez MA, Gutiérrez-Reyes G, Cortina D, Oregel JA, Pérez-Pruna C, Sixtos MS, Cruz-Castellanos S, Soto-Ramírez LE, Rodríguez-Díaz R, Fuentes-Romero L, Gutiérrez-Ruiz MC, Kershenobich D.
    Rev Invest Clin; 2003 May; 55(2):138-42. PubMed ID: 12827916
    [Abstract] [Full Text] [Related]

  • 6. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO.
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy of and indications for IFN retreatment of patients with chronic hepatitis C].
    Iyoda K, Kato M.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):502-5. PubMed ID: 15359850
    [No Abstract] [Full Text] [Related]

  • 8. What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: viral dynamics, viral levels at certain time points, or a combination of both?
    Weiland O.
    J Hepatol; 2009 Jul; 51(1):4-7. PubMed ID: 19446915
    [No Abstract] [Full Text] [Related]

  • 9. Long-term re-treatment with interferon and ribavirin combination therapy in patients with chronic hepatitis C who are non-responders to interferon alone: a preliminary study.
    Vega P, Castro A, Hermida M, López Calvo S, Pedreira J.
    Scand J Infect Dis; 1999 Jul; 31(4):359-61. PubMed ID: 10528873
    [Abstract] [Full Text] [Related]

  • 10. A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms.
    Ma P, Yang JM, Hou W, Song SD, Wang L, Lu W.
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):601-5. PubMed ID: 23263720
    [Abstract] [Full Text] [Related]

  • 11. Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?
    Bizollon T, Trepo C.
    J Hepatol; 2002 Aug; 37(2):274-6. PubMed ID: 12127435
    [No Abstract] [Full Text] [Related]

  • 12. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, Rizzetto M, Saracco G.
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [Abstract] [Full Text] [Related]

  • 13. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
    Jessner W, Der-Petrossian M, Christiansen L, Maier H, Steindl-Munda P, Gangl A, Ferenci P.
    Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
    [No Abstract] [Full Text] [Related]

  • 14. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
    Manns M, Marcellin P, Poordad F, de Araujo ES, Buti M, Horsmans Y, Janczewska E, Villamil F, Scott J, Peeters M, Lenz O, Ouwerkerk-Mahadevan S, De La Rosa G, Kalmeijer R, Sinha R, Beumont-Mauviel M.
    Lancet; 2014 Aug 02; 384(9941):414-26. PubMed ID: 24907224
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of measuring HCV-RNA levels in patients with chronic hepatitis C by IFN treatment, including combination therapy with ribavirin].
    Kakumu S.
    Nihon Rinsho; 2004 Jul 02; 62 Suppl 7(Pt 1):507-10. PubMed ID: 15359851
    [No Abstract] [Full Text] [Related]

  • 16. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination].
    Niederau C.
    MMW Fortschr Med; 2008 Mar 27; 150(13):26. PubMed ID: 18522352
    [No Abstract] [Full Text] [Related]

  • 17. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.
    McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C, Dienstag J, Lee WM, Mak C, Garaud JJ, Albrecht JK, International Hepatitis Interventional Therapy Group.
    Gastroenterology; 2002 Oct 27; 123(4):1061-9. PubMed ID: 12360468
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
    Serfaty L.
    Gastroenterol Clin Biol; 2002 Apr 27; 26 Spec No 2():B202-5. PubMed ID: 12180289
    [No Abstract] [Full Text] [Related]

  • 19. Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C.
    Vigani AG, Pavan MH, Tozzo R, Gonçales ES, Lazarini MS, Oliveira AM, Gonçales FL.
    Braz J Infect Dis; 2010 Apr 27; 14(2):193-6. PubMed ID: 20563450
    [Abstract] [Full Text] [Related]

  • 20. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
    MMW Fortschr Med; 2002 Nov 07; 144(45):56-7. PubMed ID: 12534066
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.